Baghrous , S. (2025) “Beyond Current Therapies: In Silico Drug Repurposing as a Strategy to Overcome Tyrosine Kinase Inhibitor Resistance in NSCLC”, Journal of Drug Delivery and Therapeutics, 15(8), pp. 207–216. doi:10.22270/jddt.v15i8.7276.